Search
for
Sort by
Research 31–60 of 518
- Multiple sclerosis disease-modifying therapies: adverse effect surveillance and management
- Hair Tourniquet Syndrome of the Toe: Report of 2 New Cases
- Forensics in dermatology: Part II
- Aggressive squamous cell carcinoma developing in a giant epidermal cyst of the abdomen
- Clinically-Relevant Chemotherapy Interactions with Complementary and Alternative Medicines in Patients with Cancer
- Lupus erythematosus-like lesions in a carrier of X-linked chronic granulomatous disease: A case report and personal considerations
- A Primary Adrenal Non-Hodgkin's Lymphoma Presenting as an Incidental Adrenal Mass
- Pharmacovigilance in Pediatric Patients with Epilepsy Using Antiepileptic Drugs
- Low serum biotin in Japanese children fed with hydrolysate formula
- Management of transgender patients in critical care
- Clinical Guidance on the Monitoring and Management of Trastuzumab Deruxtecan (T-DXd)-Related Adverse Events: Insights from an Asia-Pacific Multidisciplinary Panel
- Childhood‐onset systemic lupus erythematosus with trisomy X and the increased risk for bone complications: a case report
- Heavy Metals (Cadmium, Zinc, Nickel, Chrome, Lead, and Copper) Contamination in Kohl Available in Iran’s Market
- Nonalcoholic fatty liver disease in young adult Egyptian women with polycystic ovary syndrome
- A disproportionality analysis of adverse events caused by pexidartinib from the FDA adverse event reporting system
- Episodes of Keratitis during Treatment with Baricitinib for Alopecia Areata
- Crescent‐shaped incisional cuts: An unusual complication with Q‐switched Nd:YAG 1064 laser tattoo removal
- Isolation and structural identification of a novel minoxidil analogue in an illegal dietary supplement: triaminodil
- Eosinophilia associated with clozapine – A case report
- Sensitization and Clinically Relevant Allergy to Hair Dyes and Clothes from Black Henna Tattoos: Do People Know the Risk? An Uncommon Serious Case and a Review of the Literature
- CARDIOVASCULAR SAFETY OF LOW-DOSE ORAL MINOXIDIL FOR ANDROGENETIC ALOPECIA IN PATIENTS WITH HYPERTENSION OR ARRHYTHMIAS
- Acute Onset of Vitiligo in a Patient with Graves’ Disease and Recurrent Alopecia Areata
- Drug-associated insomnia: A pharmacovigilance study based on FDA adverse event reporting system
- Evaluating the safety profile of α-1 blockers, 5α-reductase inhibitors, and PDE5I for BPH: a disproportionality analysis of real-world adverse events based on FDA adverse event reporting system (FAERS)
- Comparative safety profiles of baricitinib and tofacitinib in the treatment of adult alopecia areata: a pharmacovigilance study based on the FAERS database
- Signal Detection of Depression and Suicidality Associated with Finasteride and Dutasteride: Updated Pharmacovigilance Evidence and Recommendations for Comprehensive Psychiatric Assessment
- A Study of Cutaneous Manifestations in Patients During the Post-COVID Period in A Tertiary Care Center
- SUN-439 Hypothalamic-Pituitary-Adrenal Axis Disruption from Unregulated Glucocorticoid Use: A Case Series
- MON-407 The Double-Edged Sword of Methimazole: Managing Graves' Disease with a Twist
- Trichodaganomania: A Curious Habit